16.4 Protection from Light and Freezing Exposure to extreme conditions must be avoided: Do not freeze Protect from direct light 17
Key Facts There have been 38 reports of counterfeit semaglutidethe generic name for Ozempic, Wegovy and Rybelsusin the Food and Drug Administrations Adverse Events Reporting System since 2020, with the most recent reported on October 5
Like tight junctions in the gut, the tight junctions between the endothelial cells are made up of claudins, occludins, and junction adhesion molecules
Background and aims: Cardiovascular and kidney diseases are traditional complications and leading causes of hospitalisations in people with diabetes

News provided by Eli Lilly and Company Jul 23, 2026, 06:45 ET In TRIUMPH-2, adults with obesity or overweight and type 2 diabetes, a population with increased difficulties losing weight, lost up to an average of 49.6 lbs (20.8%) at 80 weeks In TRIUMPH-3, adults with severe obesity and established cardiovascular disease, with or without type 2 diabetes, lost up to an average of 55.8 lbs (22.6%) at 80 weeks Lilly plans to submit a Biologics License Application (BLA) for retatrutide to FDA in Q1 2027 INDIANAPOLIS, July 23, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-2 and TRIUMPH-3, two pivotal Phase 3 trials evaluating retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist

L-ascorbic acid (vitamin C), L-glutamine, magnesium citrate (magnesium), potassium citrate (potassium), beetroot powder concentrate, sweeteners: sucralose, acesulfame K